R. Piyananjaruhsri, “BALOXAVIR: ANTI-INFLUENZA VIRUS AGENT VIA INHIBITION OF CAP-DEPENDENT ENDRONUCLEASE”, Thai Bull Pharm Sci, vol. 15, no. 1, pp. 91–108, May 2020.